SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-008533
Filing Date
2022-11-14
Accepted
2022-11-14 16:40:46
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1332478
2 CERTIFICATION vnrx_ex311.htm EX-31.1 7397
3 CERTIFICATION vnrx_ex312.htm EX-31.2 7788
4 CERTIFICATION vnrx_ex321.htm EX-32.1 5419
  Complete submission text file 0001477932-22-008533.txt   5705629

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20220930.xsd EX-101.SCH 70303
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20220930_lab.xml EX-101.LAB 357333
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20220930_cal.xml EX-101.CAL 42610
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20220930_pre.xml EX-101.PRE 301859
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20220930_def.xml EX-101.DEF 206408
53 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 890506
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 221386720
SIC: 2835 In Vitro & In Vivo Diagnostic Substances